1stOncology™: Cancer Intelligence Service – Page 15519 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

2018 RBC Capital Market’s Global Healthcare Conference Presentation

On February 21, 2018 PDL BioPharma, Inc. presented the 2018 RBC Capital Market’s Global Healthcare Conference presentation (Presentation, PDL BioPharma, FEB 21, 2018, View Source [SID1234524081]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

FibroGen to Report Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018

On February 21, 2018 FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, reported that it will report fourth quarter and full year 2017 financial results on Tuesday, February 27, 2018 after market close, and will host a conference call to discuss financial results and provide a business update at 5:00 p.m. ET (2:00 p.m. PT) (Press release, FibroGen, FEB 21, 2018, View Source;p=RssLanding&cat=news&id=2333605 [SID1234524080]).

Conference Call and Audio Webcast
Interested parties may access a live audio webcast of the conference call via the investor section of the FibroGen website, www.fibrogen.com. It is recommended that listeners access the website 15 minutes prior to the start of the call to download and install any necessary audio software. A replay of the webcast will be available shortly after the call for a period of two weeks. To access the replay, please dial (888) 843-7419 (domestic) or (630) 652-3042 (international), and use passcode 46307822#.

Dial-In Information
Live (U.S./Canada): (888) 771-4371
Live (International): (847) 585-4405
Confirmation number: 46307822

AVEO Oncology at the RBC Capital Markets Healthcare Conference

On February 21, 2018 AVEO Oncology reported that it will present at the RBC Capital Markets Healthcare Conference
Wednesday, February 21, 2018 10:00 a.m. ET (Press release, AVEO, FEB 21, 2018, View Source;p=RssLanding&cat=events&id=5268350 [SID1234524064])

EVENT DETAILS
Title AVEO Oncology at the RBC Capital Markets Healthcare Conference
Date and Time Wednesday, February 21, 2018 10:00 a.m. ET

Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast

On February 20, 2018 Nordic Nanovector ASA (OSE: NANO) reported its fourth quarter and full year 2017 results on Tuesday, 27th of February 2018 (Press release, Nordic Nanovector, FEB 20, 2018, View Source [SID1234553512]).

A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CET at:

Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo

Meeting Room: NYLAND

The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media

The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim Reports/2017 from 7:00 am CET the same day.

10-K – Annual report [Section 13 and 15(d), not S-K Item 405]

Eli Lilly has filed a 10-K – Annual report [Section 13 and 15(d), not S-K Item 405] with the U.S. Securities and Exchange Commission (Filing, 10-K, Eli Lilly, 2018, FEB 20, 2018, View Source [SID1234524061]).